Global Single-Cell Analysis Market Report and Forecast 2024-2032

Global Single-Cell Analysis Market Outlook

The global single-cell analysis market attained a value of about USD 3.30 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 14.7% to reach nearly USD 11.28 billion by 2032.       

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America is the Significant Market Contributing to the Market Growth of Single-Cell Analysis

North America is a significant single-cell analysis industry. This is attributed to the well-developed healthcare infrastructure, expanding medical research facility, collaborative efforts of key market players, and increased government and private support for research projects. Further, the rising public awareness due to the high incidence of chronic diseases in the region has stimulated the market growth of single-cell analysis. There has been a surge in interest in virology and genomics as a research topic, especially after the outbreak of COVID-19. The increased adoption of single-cell assessment in the diagnostics and pharmaceutical manufacturing industries, along with the reducing prices of sequencing technology, is speeding the single-cell genome sequencing, consequently driving market expansion. In addition, the rising incidences of cancer have resulted in greater funding for cancer research. The single-cell analysis is expected to simplify and automate clinical diagnostic operations, delivering critical data for real-time cancer monitoring, and eventually, new therapy options for patients' benefit. This feature is expected to make analysis more efficient and precise. All these factors are expected to boost the market growth of single-cell analysis over the forecast period.

Single-Cell Analysis: Market Segmentation

Single-cell analysis is the study of genomes, transcriptomics, proteomics, metabolomics, and cell–cell interactions at the unicellular level. It reveals new information about the functional differences between individual cells and molecules, the organisation and timing of stimuli responses, cellular interactions as components of a complex system, and how they change with age, disease, and environmental stressors.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

On the basis of products, the market is divided into:

• Consumables
  • Reagents 
  • Assay Kits
• Instruments
  • Microscopes
  • Haemocytometers
  • Flow Cytometers
  • Next Generation Sequencing 
  • Polymerase Chain Reaction
  • High Content Screening Systems
  • Cell Microarrays
  • Automated Cell Counters
  • Single Live Cell Imaging

The market can be broadly categorised on the basis of its applications into:

• Cancer
• Immunology
• Neurology
• Stem Cell
• Non-Invasive Prenatal Diagnosis
• In-vitro Fertilisation
• Others

The market can be broadly categorised on the basis of its work flow into:

• Single-Cell Isolation and Library
• Downstream Analysis
• Data Analysis

The market can be broadly categorised on the basis of its end-use segments into:

• Academic and Research Laboratories
• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostics Laboratories
• Others

The EMR report looks into the regional markets of single-cell analysis like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Health Awareness Boosting the Market Growth of Single-Cell Analysis

The market for single-cell analysis is being driven by the increasing disposable incomes and rising health awareness, which has surged the demand for early diagnosis among the masses. Due to this, governments and private players are extending a great amount of funding to research and development. The onset of COVID-19 has increased the application of single-cell analysis in virology by manyfold. The use of a high-throughput single-cell analysis approach aids in the evaluation of COVID-19 patients' immune responses. The rapid growth of healthcare infrastructure, technological improvements in single-cell analysis methodologies, and an increase in the biotechnology and biopharmaceutical industries have all facilitated the market. The falling cost of genome sequencing is also a major driver of the market. However, the technology and tools required in the single-cell analysis are expensive and hence restrain the research community.

Key Industry Players in the Global Single-Cell Analysis Market

The report presents a detailed analysis of the following key players in the global single-cell analysis market globally, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Thermo Fisher Scientific, Inc.
• QIAGEN N.V.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Becton, Dickinson and Company
• Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report